Lacidipine

Standard products

CAS-RN 103890-78-4
Documentation EDMF
Specification B.P.
Therapeutic use Antihypertensive agent:
calcium channel blocker


Description White to pale yellow powder
IR Spectrum Corresponds to reference spectrum
Identification B Rt principal peak Assay
Related substances (HPLC)
· Identification Rt similar to standard
· Impurity A Not more than 0.15%
· Impurity B Not more than 0.2%
· Impurity C Not more than 0.2%
· Other impurities Not more than 0.10%
· Total impurities Not more than 0.5%
Water Not more than 0.2%
Residual 2-propanol Not more than 0.5%
Assay 97.5 – 102.0%

Products protected by patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. Samples of products under patent can be supplied only for R&D purposes.